Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in Peru. (Q48718659)
Jump to navigation
Jump to search
scientific article published in May 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in Peru. |
scientific article published in May 1997 |
Statements
1 reference
Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in Peru. (English)
1 reference
Garcia HH
1 reference
Gilman RH
1 reference
Horton J
1 reference
Martinez M
1 reference
Herrera G
1 reference
Altamirano J
1 reference
Cuba JM
1 reference
Rios-Saavedra N
1 reference
Verastegui M
1 reference
Boero J
1 reference
Gonzalez AE
1 reference
1 May 1997
1 reference
1 reference
48
1 reference
1421-1427
1 reference
5
1 reference
Identifiers
1 reference
1 reference